Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
GOLGA8H (N-term), 19-45 | polyclonal | Rabbit | human | peptide affinity purified | 0.08 mL, 0.4 mL | n/a |
MYBIOSOURCE INC. |
More Info |
Mouse Hoxb1 (N-term), 19-46 | polyclonal | Rabbit | mouse | peptide affinity purified | 0.08 mL, 0.4 mL | n/a |
MYBIOSOURCE INC. |
More Info |
NPY2R (N-term), 19-45 | polyclonal | Rabbit | human, mouse | peptide affinity purified | 0.08 mL, 0.4 mL | n/a |
MYBIOSOURCE INC. |
More Info |
ODF3B (N-term), 19-47 | polyclonal | Rabbit | human, mouse | peptide affinity purified | 0.08 mL, 0.4 mL | n/a |
MYBIOSOURCE INC. |
More Info |
RNF19A, 30-110 N-terminal | polyclonal | Rabbit | human, mouse | affinity purified | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
SEMA6D (N-term), 19-48 | polyclonal | Rabbit | human, mouse | peptide affinity purified | 0.08 mL, 0.4 mL | n/a |
MYBIOSOURCE INC. |
More Info |
SLC19A1 - N-terminal region | polyclonal | Rabbit | human | Protein A purified | 0.1 mL | n/a |
MYBIOSOURCE INC. |
More Info |
SHH | polyclonal | Rabbit | mouse | unconjugated | 10 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike Protein (Bebtelovimab biosimilar) | monoclonal | Recombinant Human | n/a | Protein A purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
ASY1 | polyclonal | Rabbit | A. thaliana | unconjugated | 10 mg | n/a |
BIORBYT LTD. |
More Info |
NAA15 - C-terminal region | polyclonal | Rabbit | human | affinity purified | 0.1 mL | n/a |
MYBIOSOURCE INC. |
More Info |
NARG1 | polyclonal | Rabbit | human, mouse | immunogen affinity purified | 0.05 mg, 0.1 mg | n/a |
MYBIOSOURCE INC. |
More Info |
NARG1 - N-terminal region | polyclonal | Rabbit | cow, dog, guinea pig, horse, human, mouse, rabbit, rat, zebrafish | affinity purified | 0.1 mL | n/a |
MYBIOSOURCE INC. |
More Info |
SARS-CoV-2 Spike Glycoprotein S1 Subunit | 42 | Mouse | SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV-2 Spike Glycoprotein S1 Subunit | polyclonal | Rabbit | SARS-CoV-2, SARS-CoV | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV-2 Spike Glycoprotein S1 Subunit | polyclonal | Rabbit | SARS-CoV-2, SARS-CoV | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV-2 Spike Glycoprotein S2 Subunit Extracellular Domain | D001 | Chimeric | SARS-CoV-2; | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |